Secondary binding site of the potato carboxypeptidase inhibitor. Contribution to its structure, folding, and biological properties

Biochemistry

Volumn 43, Issue 24, 2004, Pages 7973-7982

  Arolas, Joan L ^a   Lorenzo, Julia ^a   Rovira, Ana ^a   Vendrell, Josep ^a   Aviles, Francesc X ^a   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; BIOTECHNOLOGY; COMPLEXATION; ENZYME INHIBITION; MOLECULAR STRUCTURE; MUTAGENESIS; QUENCHING;

BINDING SITES; INTRAMOLECULAR CONTACTS;

BIOCHEMISTRY;

ALANINE; CARBOXYPEPTIDASE; CARBOXYPEPTIDASE A; DISULFIDE; ENZYME INHIBITOR; MUTANT PROTEIN;

ARTICLE; BINDING SITE; BIOTECHNOLOGY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITION; FORCE; MOLECULAR INTERACTION; MUTAGENESIS; NONHUMAN; OXIDATION; POTATO; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN STRUCTURE;

BINDING SITES; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OXIDATION-REDUCTION; PLANT PROTEINS; PROTEIN CONFORMATION; PROTEIN FOLDING; SOLANUM TUBEROSUM; THERMODYNAMICS;

SOLANUM TUBEROSUM;

EID: 2942711678     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049596j     Document Type: Article

References (44)

1. Otlewski, J., and Apostoluk, W. (1997) Structural and energetic aspects of protein-protein recognition, Acta Biochim. Pol. 44, 367-387.
2. Edwards, A. M., Kus, B., Jansen, R., Greenbaum, D., Greenbatt, J., and Gerstein, M. (2002) Bridging structural biology and genomics: assessing protein interaction data with known complexes, Trends Genet. 18, 529-536.
3. Nooren, I. M., and Thornton, J. M. (2003) Diversity of protein-protein interactions, EMBO J. 22, 3486-3492.
4. Bode, W., and Huber, R. (2000) Structural basis of the endoproteinase-protein inhibitor interaction, Biochim. Biophys. Acta 1477, 241-252.
5. Vendrell, J., Querol, E., and Aviles, F. X. (2000) Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties, Biochim. Biophys. Acta 1477, 284-298.
6. Coughlin, S. R. (2000) Thrombin signalling and protease-activated receptors, Nature 14, 258-264.
7. Turk, B., Stoka, V., Rozman-Pungercar, J., Cirman, T., Droga-Mazovec, G., Oreic, K., and Turk, V. (2002) Apoptotic pathways: involvement of lysosomal proteases, Biol. Chem. 383, 1035-1044.
8. Stamenkovic, I. (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases, J. Pathol. 200, 448-464.
9. Hass, G. M., and Ryan, C. A. (1981) Carboxypeptidase inhibitor from potatoes, Methods Enzymol. 80, 778-791.
10. Clore, G. M., Gronenborn, A. M., Nilges, M., and Ryan, C. A. (1987) Three-dimensional structure of potato carboxypeptidase inhibitor in solution. A study using nuclear magnetic resonance, distance geometry, and restrained molecular dynamics, Biochemistry 26, 8012-8023.
11. 15N NMR, Proteins 50, 410-422.
12. Rees, D. C., and Lipscomb, W. N. (1982) Refined crystal structure of the potato inhibitor complex of carboxypeptidase A at 2.5 Å resolution, J. Mol. Biol. 160, 475-498.
13. Lin, S. L., and Nussinov, R. (1995) A disulphide-reinforced structural scaffold shared by small proteins with diverse functions, Nat. Struct. Biol. 2, 835-837.
14. Molina, M. A., Marino, C., Oliva, B., Aviles, F. X., and Querol, E. (1994) C-tail valine is a key residue for stabilization of complex between potato inhibitor and carboxypeptidase A, J. Biol. Chem. 269, 21467-21472.
15. Marino-Buslje, C., Venhudova, G., Molina, M. A., Oliva, B., Jorba, X., Canals, F., Aviles, F. X., and Querol, E. (2000) Contribution of C-tail residues of potato carboxypeptidase inhibitor to the binding to carboxypeptidase A. A mutagenesis analysis, Eur. J. Biochem. 267, 1502-1509.
16. Creighton, T. E. (1986) Disulfide bonds as probes of protein folding pathways, Methods Enzymol. 131, 83-106.
17. Creighton, T. E. (1990) Protein folding, Biochem. J. 270, 1-16.
18. Chang, J. Y. (1997) A two-stage mechanism for the reductive unfolding of disulfide-containing proteins, J. Biol. Chem. 272, 69-75.
19. Chang, J. Y. (1999) Denatured states of tick anticoagulant peptide. Compositional analysis of unfolded scrambled isomers, J. Biol. Chem. 274, 123-128.
20. Chang, J. Y., Canals, F., Schindler, P., Querol, E., and Aviles, F. X. (1994) The disulfide folding pathway of potato carboxypeptidase inhibitor, J. Biol. Chem. 269, 22087-22094.
21. Venhudova, G., Canals, F., Querol, E., and Aviles, F. X. (2001) Mutations in the N- and C-terminal tails of potato carboxypeptidase inhibitor influence its oxidative refolding process at the reshuffling stage, J. Biol. Chem. 276, 11683-11690.
22. Chatrenet, B., and Chang, J. Y. (1993) The disulfide folding pathway of hirudin elucidated by stop/go folding experiments, J. Biol. Chem. 268, 20988-20996.
23. Chang, J. Y. (1994) Controlling the speed of hirudin folding, Biochem. J. 300, 643-650.
24. Wu, J., Yang, Y., and Watson, J. T. (1998) Trapping of intermediates during the refolding of recombinant human epidermal growth factor (hEGF) by cyanylation, and subsequent structural elucidation by mass spectrometry, Protein Sci. 7, 1017-1028.
25. Chang, J. Y., Li, L., and Lai, P. H. (2001) A major kinetic trap for the oxidative folding of human epidermal growth factor, J. Biol. Chem. 276, 4845-4852.
26. Chang, J. Y. (1996) The disulfide folding pathway of tick anticoagulant peptide (TAP), a Kunitz-type inhibitor structurally homologous to BPTI, Biochemistry 35, 11702-11709.
27. Chang, J. Y., and Ballatore, A. (2000) Structure and heterogeneity of the one- and two-disulfide folding intermediates of tick anticoagulant peptide, J. Protein Chem. 19, 299-310.
28. Chang, J. Y., Li, L., Canals, F., and Aviles, F. X. (2000) The unfolding pathway and conformational stability of potato carboxypeptidase inhibitor, J. Biol. Chem. 275, 14205-14211.
29. Cunningham, B. C., and Wells, J. A. (1989) High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis, Science 244, 1081-1085.
30. Ashkenazi, A., Presta, L. G., Marsters, S. A., Camerato, T. R., Rosenthal, K. A., Fendly, B. M., and Capon, D. J. (1990) Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis, Proc. Natl. Acad. Sci. U.S.A. 87, 7150-7154.
31. Molina, M. A., Avilés, F. X., and Querol, E. (1992) Expression of a synthetic gene encoding potato carboxypeptidase inhibitor using a bacterial secretion vector, Gene 116, 129-138.
32. Morrison, J. F. (1982) The slow-binding and slow, tight-binding inhibition of enzyne-catalysed reactions, Trends Biochem. Sci. 7, 102-105.
33. Oliva, B., Wästlund, M., Nilsson, O., Cardenas, R., Querol, E., Avilés, F. X., and Tapia, O. (1991) Stability and fluctuations of the potato carboxypeptidase A protein inhibitor fold: a molecular dynamics study, Biochem. Biophys. Res. Commun. 176, 616-621.
34. Bulychev, A., and Chang, J. Y. (1999) Unfolding of hirudin characterized by the composition of denatured scrambled isomers, J. Protein Chem. 18, 771-778.
35. Salamanca, S., Villegas, V., Vendrell, J., Li, L., Aviles, F. X., and Chang, J. Y. (2002) The unfolding pathway of leech carboxypeptidase inhibitor, J. Biol. Chem. 277, 17538-17543.
36. Chang, J. Y., Li, L., and Bulychev, A. (2000) The underlying mechanism for the diversity of disulfide folding pathways, J. Biol. Chem. 275, 8287-8289.
37. Villanueva, J., Canals, F., Villegas, V., Querol, E., and Aviles, F. X. (2000) Hydrogen exchange monitored by MALDI-TOF mass spectrometry for rapid characterization of the stability and conformation of proteins, FEBS Lett. 472, 27-33.
38. Chiti, F., Taddei, N., Bucciantini, M., White, P., Ramponi, G., and Dobson, C. M. (2000) Mutational analysis of the propensity for amyloid formation by a globular protein, EMBO J. 19, 1441-1449.
39. Reverter, D., Vendrell, J., Canals, F., Horstmann, J., Aviles, F. X., Fritz, H., and Sommerhoff, C. P. (1998) A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis. Isolation, sequence analysis, cDNA cloning, recombinant expression, and characterization, J. Biol. Chem. 273, 32927-32933.
40. Nagashima, M., Werner, M., Wang, M., Zhao, L., Light, D. R., Pagila, R., Morser, J., and Verhallen, P. (2000) An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model, Thromb. Res. 98, 333-342.
41. Schneider, M., and Nesheim, M. (2003) Reversible inhibitors of TAFIa can both promote and inhibit fibrinolysis, J. Thromb. Haemostasis 1, 147-154.
42. Walker, J. B., Hughes, B., James, I., Haddock, P., Kluft, C., and Bajzar, L. (2003) Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro, J. Biol. Chem. 278, 8913-8921.
43. Bouma, B. N., and Meijers, J. C. M. (2003) Thrombin-activatable fibrinolysis inhibitor (TAFI, plasma procarboxypeptidase B, procarboxypeptidase R, procarboxypeptidase U), J. Thromb. Haemostasis 1, 1566-1574.
44. Barrow, J. C., Nantermet, P. G., Stauffer, S. R., Ngo, P. L., Steinbeiser, M. A., Mao, S. S., Carroll, S. S., Bailey, C., Colussi, D., Bosserman, M., Burlein, C., Cook, J. J., Sitko, G., Tiller, P. R., Miller-Stein, C. M., Rose, M., McMasters, D. R., Vacca, J. P., and Selnick, H. G. (2003) Synthesis and evaluation of imidazole acetic acid inhibitors of activated thrombin-activatable fibrinolysis inhibitor as novel antithrombotics, J. Med. Chem. 46, 5294-5297.